Pharmacogenomics is transforming healthcare by enabling more personalized treatment decisions based on an individual's genetic profile. As sequencing technologies continue to advance, whole genome sequencing (WGS) offers new opportunities to identify pharmacogenetic markers beyond the capabilities of traditional genotyping methods.

In this webinar, Dr. Andrea Conti from BMR Genomics presents the potential of WGS for pharmacogenetic marker evaluation and explores how comprehensive genomic data can support the future of precision medicine.

Attendees will learn:

• The role of pharmacogenomics in personalized healthcare

• How whole genome sequencing can support pharmacogenetic marker discovery

• The advantages and challenges of WGS compared to traditional genotyping approaches

• Opportunities for integrating WGS into pharmacogenomics research and clinical workflows

• Future perspectives for precision medicine and genomic-guided treatment decisions

This session is ideal for researchers, bioinformaticians, clinical geneticists, molecular diagnostics laboratories, and healthcare professionals interested in pharmacogenomics and precision medicine.